RARE stock forecast for 2023 – 2027
Last updated: April 20, 2024
Are you interested in Ultragenyx Pharmaceutical Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the RARE stock price in 2022-2027. Is RARE a good long term stock? When should I take profit in Ultragenyx Pharmaceutical stock? Buy or sell stock? Will RARE stock price go up? What are analysts’ forecasts for RARE stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. RARE stock returns are also predicted based on historical data.
According to our research, RARE stock is a good long-term investment. RARE share price has been in a bull cycle for the past year. Ultragenyx Pharmaceutical Inc. stock trend is positive.
Ultragenyx Pharmaceutical company info
| Industry | Biotechnology |
| Address | 60 Leveroni Court, Novato, CA, 94949, United States |
| Website | https://www.ultragenyx.com |
Forecasting
52 Week High: 90.6464 USD
52 Week Low: 68.6396 USD
1 Year Forecast: 88.536 USD
5 Year Forecast: 159.986 USD
Agilent Technologies info
Market Cap: 4.91B
52 Week Change: -76.505%
52 Week High: 175 USD
52 Week Low: 62.37 USD
Beta: 1.0958
50 Day Moving Average: 77.03
90 Day Moving Average: 77.805
200 Day Moving Average: 83.65
Resistance Level: 74.8569
Pivot Point: 72.5699
Support Level: 66.8973
Enterprise Value: 0
Forward P/E: 0
Forward EPS: 0
Profit Margin: 0
Shares Outstanding: 0
EBITDA: 0
Held Percent Institutions: 0
PEG Ratio (5Y): 0
Trailing EPS: 0
Ultragenyx Pharmaceutical stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
Ultragenyx Pharmaceutical Stock Forecast for 2023 | |||
| January 2023 | 87.87 | 86.86 | -1.15% |
| February 2023 | 87.72 | 92 | 4.88% |
| March 2023 | 93 | 86.13 | -7.39% |
| April 2023 | 88.88 | 89.89 | 1.14% |
| May 2023 | 88.11 | 92.12 | 4.55% |
| June 2023 | 93.06 | 96.04 | 3.2% |
| July 2023 | 100.98 | 102.01 | 1.02% |
| August 2023 | 101 | 103.02 | 2% |
| September 2023 | 99.96 | 99 | -0.96% |
| October 2023 | 102 | 95 | -6.86% |
| November 2023 | 96 | 99 | 3.13% |
| December 2023 | 97.02 | 107.06 | 10.35% |
Ultragenyx Pharmaceutical Stock Forecast for 2024 | |||
| January 2024 | 107.1 | 106.08 | -0.95% |
| February 2024 | 105.04 | 108.78 | 3.56% |
| March 2024 | 107.8 | 103.95 | -3.57% |
| April 2024 | 103.88 | 108.07 | 4.03% |
| May 2024 | 107 | 111 | 3.74% |
| June 2024 | 110.88 | 118.32 | 6.71% |
| July 2024 | 119.34 | 120 | 0.55% |
| August 2024 | 121.38 | 118.8 | -2.13% |
| September 2024 | 123.42 | 119 | -3.58% |
| October 2024 | 116.82 | 116.28 | -0.46% |
| November 2024 | 114 | 119.34 | 4.68% |
| December 2024 | 119.18 | 122.76 | 3% |
Ultragenyx Pharmaceutical Stock Forecast for 2025 | |||
| January 2025 | 122.76 | 120.78 | -1.61% |
| February 2025 | 123 | 127.71 | 3.83% |
| March 2025 | 126.42 | 126.48 | 0.05% |
| April 2025 | 125.24 | 127.26 | 1.61% |
| May 2025 | 126 | 128.7 | 2.14% |
| June 2025 | 132.6 | 137.7 | 3.85% |
| July 2025 | 135 | 135.24 | 0.18% |
| August 2025 | 134.26 | 140.76 | 4.84% |
| September 2025 | 137.61 | 137 | -0.44% |
| October 2025 | 135.63 | 130.68 | -3.65% |
| November 2025 | 135.66 | 132.3 | -2.48% |
| December 2025 | 133.28 | 144.43 | 8.37% |
Ultragenyx Pharmaceutical Stock Forecast for 2026 | |||
| January 2026 | 139.16 | 137.2 | -1.41% |
| February 2026 | 142.41 | 145.53 | 2.19% |
| March 2026 | 145.53 | 142 | -2.43% |
| April 2026 | 145.86 | 146.88 | 0.7% |
| May 2026 | 143 | 149.48 | 4.53% |
| June 2026 | 146.02 | 153 | 4.78% |
| July 2026 | 155.54 | 156 | 0.3% |
| August 2026 | 159.12 | 158.57 | -0.35% |
| September 2026 | 160.14 | 152.88 | -4.53% |
| October 2026 | 153.45 | 150 | -2.25% |
| November 2026 | 154.02 | 157.08 | 1.99% |
| December 2026 | 156.55 | 164.22 | 4.9% |
Ultragenyx Pharmaceutical Stock Forecast for 2027 | |||
| January 2027 | 161.6 | 159.58 | -1.25% |